Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Haas

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Annals of Hematology|April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trialFriederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Blood|April 21, 2012
Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cellsIngmar Bruns, Ron-Patrick Cadeddu, Ines Brueckmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Plos One|January 30, 2013
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitorsMartin Neumann, Ebru Coskun, Lars Fransecky, et al.
Plos One|May 3, 2017
Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profileUte Harrison, Muinah A Fowora, Abiodun T Seriki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2007
Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced diseaseManuel Aivado, Dimitrios Spentzos, Ulrich Germing, et al.
Immunity|January 15, 2017
Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune ResponsesDavid Druzd, Olga Matveeva, Louise Ince, et al.
Annals of Hematology|November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupEsther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Nature Microbiology|October 18, 2016
Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMsAnahita Javaheri, Tobias Kruse, Kristof Moonens, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Tumor immune escape by the loss of homeostatic chemokine expressionAndor Pivarcsi, Anja Müller, Andreas Hippe, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Annals of Hematology|April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trialFriederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Blood|April 21, 2012
Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cellsIngmar Bruns, Ron-Patrick Cadeddu, Ines Brueckmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Plos One|January 30, 2013
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitorsMartin Neumann, Ebru Coskun, Lars Fransecky, et al.
Plos One|May 3, 2017
Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profileUte Harrison, Muinah A Fowora, Abiodun T Seriki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2007
Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced diseaseManuel Aivado, Dimitrios Spentzos, Ulrich Germing, et al.
Immunity|January 15, 2017
Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune ResponsesDavid Druzd, Olga Matveeva, Louise Ince, et al.
Annals of Hematology|November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupEsther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Nature Microbiology|October 18, 2016
Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMsAnahita Javaheri, Tobias Kruse, Kristof Moonens, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Tumor immune escape by the loss of homeostatic chemokine expressionAndor Pivarcsi, Anja Müller, Andreas Hippe, et al.
Pageof 30